about
Auricular involvement of a multifocal non-AIDS Kaposi's sarcoma: a case report.Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation.Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesisExposure to HIV-protease inhibitors selects for increased expression of P-glycoprotein (ABCB1) in Kaposi's sarcoma cells.Extracellular Hsp90 serves as a co-factor for NF-κB activation and cellular pathogenesis induced by an oncogenic herpesvirus.A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication.Sulfated polymannuroguluronate inhibits Tat-induced SLK cell adhesion via a novel binding site, a KKR spatial triad.Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.KSHV targeted therapy: an update on inhibitors of viral lytic replication.Human herpesvirus 6, 7 and 8 in solid organ transplantation.Fifty-one Kaposi sarcoma patients.Do fewer cases of Kaposi's sarcoma in HIV-infected patients reflect a decrease in HHV8 seroprevalence?Ring a ring o'roses, a patient with Kaposi's? Pazopanib, pazopanib, it might go away. Mediterranean (classic) Kaposi sarcoma responds to the tyrosine kinase inhibitor pazopanib after multiple lines of standard therapy.
P2860
Q33628508-7FDEE17B-6A0A-4FE5-9B9B-EF17897A7F8DQ34644229-120F34D2-A3E6-4229-B730-401C39DF6BB7Q35124404-A40C04FD-DD4A-4874-B4FB-33C90CF06D15Q35208091-9151CEA6-F145-4326-AA82-F113E72B32F5Q35298119-4F3E1EFA-D88B-45D7-8123-0D2C52FEBBFFQ36415707-898656F3-BC99-4318-BF20-3F028872AC1CQ37525707-CEC6F2CC-2C17-40F8-8C5D-EE69C910F165Q37728355-0F3FAFA0-90E6-4987-A8B3-074D11B04AF6Q37810431-3801B26F-D597-45FE-924A-B3C7DF1380D3Q38271135-E5242539-BC52-4672-BA6D-95F41C439F1BQ42272326-230936B0-ED9B-4CDF-8177-0A961C839C58Q43911660-0406DD08-40B0-446D-9E1A-C863211974EBQ44417541-8D387AB7-393D-4535-95B0-AD1D872F363BQ48339526-C709319C-99C0-48CC-86BC-3FA3D8065717
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted therapy for Kaposi sarcoma.
@en
Targeted therapy for Kaposi sarcoma.
@nl
type
label
Targeted therapy for Kaposi sarcoma.
@en
Targeted therapy for Kaposi sarcoma.
@nl
prefLabel
Targeted therapy for Kaposi sarcoma.
@en
Targeted therapy for Kaposi sarcoma.
@nl
P2093
P2860
P1433
P1476
Targeted therapy for Kaposi sarcoma.
@en
P2093
Bruce J Dezube
Liron Pantanowitz
Ryan J Sullivan
P2860
P356
10.2165/00063030-200923020-00001
P577
2009-01-01T00:00:00Z
P5875
P6179
1005129336